Asia Pacific Blood Screening Market _Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Asia Pacific Blood Screening Market _Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025


  • Products Id :- DBMR741
  • |
  • Pages: 100
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Market Definition

Blood is an essential requirement for health care which helps in the proper functioning of the human body. A blood screening is defined as a medical process for the detection of disease. The process of blood screening is carried out for a variety of reasons in which the most common reason is pregnancy, human immunodeficiency (HIV) and blood type screenings. Screening of the blood may also be done to detect conditions such as general infections and cancer. Different types of assays are performed in detecting health related problems. Collected blood is screened with different techniques such as ELISA, NAT technology, next generation sequencing and many others. EIAs, particle agglutination (rapid tests) and (Chemiluminescence Immunoassays) CLIAs assays are used for blood screening. Most (Chemiluminescence Immunoassays) CLIAs consists greater specificity and sensitivity as compare to rapid tests that provides better result in screening process.

Asia Pacific Blood Screening Market is expected to reach with healthy CAGR of 10.5% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Market Segmentation

By Products & Services (Reagents & Kits, Instruments, Software & Services), Technology (Enzyme-Linked Immunosorbent Assay, Rapid Tests, Next-Generation Sequencing, Nucleic Acid Test, Western Blot Assay, Others), Disease Type (Oncology, Diabetes Mellitus, Cold & Flu, Cholesterol, Infectious Diseases, Respiratory Diseases, HIV/AIDS, Others), End User (Diagnostic Centers, Blood Bank, Hospitals, Clinics, Ambulatory Surgical Centers), Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa)

Major growing sectors under the market segmentation are as follows:

In products & services, reagents are dominating this market as reagents are majorly used in laboratory, company and other places to perform experiment and also to find or detect the diseases related to human health.

In technology, enzyme-linked immunosorbent assay (ELISA) is dominating this market as it is more used with accurate result and less costly in the market. It is a versatile tool for physicians, laboratories, and medical professionals all over the world.

In disease type, oncology is dominating this market as increasing population is detecting more with cancer cases due to exposure to UV lights in today's world. The Blood screening method is found to be more useful for detecting cancer.

In end user, diagnostic centers is dominating this market as people mostly prefer diagnostics centers and doctors also suggest patients to visit diagnostics center for detection of diseases.

The key market players for Asia Pacific blood screening market are listed below:

Enzo Biochem Inc.

Meridian Bioscience, Inc.

Bio-Rad Laboratories, Inc.

Thermo Fisher Scientific Inc.

BD

bioMerieux SA

Beckman Coulter, Inc.

Abbott

F. Hoffmann-La Roche Ltd

Cepheid

Grifols

Seimens AG

Ortho Clinical Diagnostics

Immucor, Inc.

Hologic Inc.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

TABLE OF CONTENTS

1 INTRODUCTION 30

1.1 OBJECTIVES OF THE STUDY 30

1.2 MARKET DEFINITION 30

1.3 OVERVIEW OF ASIA-PACIFIC BLOOD SCREENING MARKET 30

1.4 CURRENCY AND PRICING 31

1.5 LIMITATION 32

1.6 MARKETS COVERED 32

2 MARKET SEGMENTATION 36

2.1 MARKETS COVERED 36

2.2 GEOGRAPHIC SCOPE 37

2.3 YEARS CONSIDERED FOR THE STUDY 38

2.4 CURRENCY AND PRICING 38

2.5 RESEARCH METHODOLOGY 39

2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 42

2.7 DBMR MARKET POSITION GRID 43

2.8 THE CATEGORY VS TIME GRID 44

2.9 THE CATEGORY VS TIME GRID 45

2.10 DBMR MARKET CHALLENGE MATRIX 46

2.11 SECONDARY SOURCES 47

2.12 ASSUMPTIONS 47

3 MARKET OVERVIEW 48

3.1 DRIVERS 50

3.1.1 RISE IN THE DEMAND OF BLOOD DONATIONS AND BLOOD DONORS 50

3.1.2 RISING PREVALENCE IN NUMBER OF DISEASES 50

3.1.3 RISING NUMBER OF INITIATIVES BY VARIOUS GOVERNMENTS AND GOVERNMENT ASSOCIATIONS 51

3.2 RESTRAINTS 52

3.2.1 LACK OF USING NAT TECHNLOGY IN EMERGING COUNTRIES 52

3.2.2 HIGH COST OF TECHNOLOGY AND INSTRUMENTS 52

3.2.3 EMERGING ALTERNATIVE TECHNOLOGIES 53

3.3 OPPORTUNITIES 54

3.3.1 INCREASING MICROBIOLOGY SCREENING & MULTIPLEXING 54

3.4 CHALLENGES 55

3.4.1 REDUCTION IN PRICE FOR TECHNOLOGY AND INSTRUMENT 55

4 EXECUTIVE SUMMARY 56

5 PREMIUM INSIGHTS 59

6 ASIA-PACIFIC BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES 62

6.1 OVERVIEW 63

6.2 REAGENTS & KITS 65

6.2.1 ELISA REAGENTS & KITS 67

6.2.1.1 IMMUNOSORBENTS 68

6.2.1.2 CONJUGATES 68

6.2.1.3 SUBSTRATES 68

6.2.1.4 CONTROLS 68

6.2.1.5 SAMPLE DILUENTS AND WASH SOLUTIONS 68

6.2.2 NAT REAGENTS & KITS 68

6.2.2.1 PROBES AND PRIMERS 69

6.2.2.2 ENZYMES AND POLYMERASES 69

6.2.2.3 LABELING AND DETECTION REAGENTS 69

6.2.2.4 STANDARDS AND CONTROLS 69

6.2.2.5 BUFFERS, NUCLEOTIDES AND SOLUTIONS 69

6.3 INSTRUMENTS 70

6.3.1.1 INSTRUMENTS, PRODUCT TYPE 71

6.3.1.1.1 SEMI AUTOMATED 71

6.3.1.1.2 AUTOMATED 71

6.3.1.2 INSTRUMENTS, PURCHASE TYPE 71

6.3.1.2.1 OUTRIGHT PURCHASE 71

6.3.1.2.2 RENTAL 71

6.4 SOFTWARE & SERVICES 72

7 ASIA-PACIFIC BLOOD SCREENING MARKET, BY TECHNOLOGY 73

7.1 OVERVIEW 74

7.2 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) 76

7.2.1 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY PLATFORM 78

7.2.1.1 COLORIMETRIC IMMUNOASSAY (CI) 78

7.2.1.2 CHEMILUMINESCENCE IMMUNOASSAY (CLIA) 78

7.2.1.3 FLUORESCENCE IMMUNOASSAY (FIA) 78

7.2.2 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY GENERATIONS 78

7.2.2.1 FIRST-GENERATION ELISA 78

7.2.2.2 SECOND-GENERATION ELISA 78

7.2.2.3 THIRD-GENERATION ELISA 78

7.2.2.4 FOURTH-GENERATION ELISA 78

7.3 RAPID TESTS 79

7.4 NEXT-GENERATION SEQUENCING (NGS) 80

7.5 NUCLEIC ACID TEST 81

7.5.1 REAL-TIME POLYMERASE CHAIN REACTION (PCR) 82

7.5.2 TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA) 82

7.6 WESTERN BLOT ASSAY 83

7.7 OTHERS 84

8 ASIA-PACIFIC BLOOD SCREENING MARKET, BY DISEASE TYPE 85

8.1 OVERVIEW 86

8.2 ONCOLOGY 88

8.3 DIABETES MELLITUS 89

8.4 COLD & FLU 90

8.5 CHOLESTEROL 91

8.6 INFECTIOUS DISEASES 92

8.7 RESPIRATORY DISEASES 93

8.8 HIV/AIDS 94

8.9 OTHERS 95

9 ASIA-PACIFIC BLOOD SCREENING MARKET, BY END USER 96

9.1 OVERVIEW 97

9.2 DIAGNOSTIC CENTERS 99

9.3 BLOOD BANK 100

9.4 HOSPITALS 101

9.5 CLINICS 102

9.6 AMBULATORY SURGICAL CENTERS 103

10 ASIA-PACIFIC BLOOD SCREENING MARKET, BY GEOGRAPHY 104

10.1 ASIA-PACIFIC 104

10.1.1 CHINA 115

10.1.2 JAPAN 122

10.1.3 SOUTH KOREA 129

10.1.4 INDIA 136

10.1.5 SINGAPORE 143

10.1.6 AUSTRALIA 150

10.1.7 THAILAND 157

10.1.8 MALAYSIA 164

10.1.9 INDONESIA 171

10.1.10 PHILIPPINES 178

10.1.11 REST OF ASIA-PACIFIC 185

11 ASIA-PACIFIC BLOOD SCREENING MARKET, COMPANY LANDSCAPE 186

11.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 186

12 COMPANY PROFILES 187

12.1 F. HOFFMANN-LA ROCHE LTD 187

12.1.1 COMPANY OVERVIEW 187

12.1.2 REVENUEANALYSIS 187

12.1.3 COMPANY SHARE ANALYSIS 188

12.1.4 PRODUCT PORTFOLIO 188

12.1.5 RECENT DEVELOPMENT 189

12.2 ABBOTT 190

12.2.1 COMPANY OVERVIEW 190

12.2.2 REVENUE ANALYSIS 190

12.2.3 COMPANY SHAREV ANALYSIS 191

12.2.4 PRODUCT PORTFOLIO 191

12.2.5 RECENT DEVELOPMENT 192

12.3 THERMO FISHER SCIENTIFIC INC. 193

12.3.1 COMPANY OVERVIEW 193

12.3.2 REVENUE ANALYSIS 193

12.3.3 COMPANY SHAREV ANALYSIS 194

12.3.4 PRODUCT PORTFOLIO 194

12.3.5 RECENT DEVELOPMENTS 195

12.4 SIEMENS AG 196

12.4.1 COMPANY OVERVIEW 196

12.4.2 REVENUE ANALYSIS 196

12.4.3 COMPANY SHAREV ANALYSIS 197

12.4.4 PRODUCT PORTFOLIO 197

12.4.5 RECENT DEVELOPMENTS 199

12.5 BIO-RAD LABORATORIES, INC. 200

12.5.1 1.3.1COMPANY OVERVIEW 200

12.5.2 REVENUE ANALYSIS 200

12.5.3 COMPANY SHAREV ANALYSIS 201

12.5.4 PRODUCT PORTFOLIO 201

12.5.5 RECENT DEVELOPMENTS 203

12.6 BD 204

12.6.1 COMPANY OVERVIEW 204

12.6.2 REVENUE ANALYSIS 204

12.6.3 PRODUCT PORTFOLIO 205

12.6.4 RECENT DEVELOPMENTS 205

12.7 BECKMAN COULTER, INC. 206

12.7.1 COMPANY OVERVIEW 206

12.7.2 GEOGRAPHICPRESENCE 206

12.7.3 PODUCT PORTFOLIO 207

12.7.4 RECENET DEVELOPEMENTS 208

12.8 BIOMERIEUX SA 209

12.8.1 COMPANY OVERVIEW 209

12.8.2 REVENUE ANALYSIS 209

12.8.3 PRODUCT PORTFOLIO 210

12.8.4 RECENT DEVELOPMENT 211

12.9 CEPHEID (A SUBSIDIARY OF DANAHER CORPORATION) 212

12.9.1 COMPANY OVERVIEW 212

12.9.2 GEOGRAPHIC PRESENCE 212

12.9.3 PRODUCT PORTFOLIO 213

12.9.4 RECENT DEVELOPMENT 214

12.10 ENZO BIOCHEM INC. 215

12.10.1 COMPANY OVERVIEW 215

12.10.2 REVENUE ANALYSIS 215

12.10.3 PRODUCT PORTFOLIO 216

12.10.4 RECENT DEVELOPMENTS 217

12.11 GRIFOLS INTERNATIONAL, S.A. 218

12.11.1 COMPANY OVERVIEW 218

12.11.2 REVENUE ANALYSIS 218

12.11.3 PRODUCT PORTFOLIO 219

12.11.4 RECENT DEVELOPMENTS 220

12.12 HOLOGIC INC. 221

12.12.1 COMPANY OVERVIEW 221

12.12.2 REVENUE ANALYSIS 221

12.12.3 PRODUCT PORTFOLIO 222

12.12.4 RECENT DEVELOPMENTS 222

12.13 IMMUCOR, INC. 223

12.13.1 COMPANY OVERVIEW 223

12.13.2 GEOGRAPHIC PRESENCE: 223

12.13.3 PRODUCT PORTFOLIO 224

12.13.4 RECENT DEVELOPMENTS 225

12.14 MERIDIAN BIOSCIENCE, INC. 226

12.14.1 COMPANY OVERVIEW 226

12.14.2 REVENUE ANALYSIS 226

12.14.3 PRODUCT PORTFOLIO 227

12.14.4 RECENT DEVELOPMENTS 228

12.15 ORTHO CLINICAL DIAGNOSTICS 229

12.15.1 COMPANY OVERVIEW 229

12.15.2 GEOGRAPHIC PRESENCE 229

12.15.3 PRODUCT PORTFOLIO 230

12.15.4 RECENT DEVELOPMENTS 231

13 RELATED REPORTS 232

LIST OF FIGURES

FIGURE 1 ASIA-PACIFIC BLOOD SCREENING MARKET: SEGMENTATION 24

FIGURE 2 ASIA-PACIFIC BLOOD SCREENING MARKET: DATA TRIANGULATION 27

FIGURE 3 ASIA-PACIFIC BLOOD SCREENING MARKET: DROC ANALYSIS 28

FIGURE 4 ASIA-PACIFIC BLOOD SCREENING MARKET:BOTTOM UP APPROACH 29

FIGURE 5 ASIA-PACIFIC BLOOD SCREENING MARKET:TOP DOWN APPROACH 29

FIGURE 6 ASIA-PACIFIC BLOOD SCREENING MARKET: INTERVIEW DEMOGRAPHICS 30

FIGURE 7 ASIA-PACIFIC BLOOD SCREENING MARKET: DBMR MARKET POSITION GRID 31

FIGURE 8 ASIA-PACIFIC BLOOD SCREENING MARKET: THE CATEGORY VS TIME GRID 32

FIGURE 9 ASIA-PACIFIC BLOOD SCREENING MARKET: THE CATEGORY VS TIME GRID 33

FIGURE 10 ASIA-PACIFIC BLOOD SCREENING MARKET: THE MARKET CHALLENGE MATRIX 34

FIGURE 11 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF ASIA-PACIFIC BLOOD SCREENING MARKET 37

FIGURE 12 ASIA-PACIFIC BLOOD SCREENING MARKET: SEGMENTATION 46

FIGURE 13 RISE IN DEMAND OF BLOOD DONATIONS AND BLOOD DONORS AS WELL AS RISING NUMBER OF INITIATIVES BY VARIOUS GOVERNMENTS AND GOVERNMENT ASSOCIATIONS EXPECTED TO DRIVE THE MARKET FOR BLOOD SCREENING MARKET IN THE FORECAST PERIOD 2018 TO 2025 47

FIGURE 14 REAGENTS & KITS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE BLOOD SCREENING MARKET IN 2018 & 2025 48

FIGURE 15 ASIA PACIFIC IS THE MAXIMUM GROWING AND MOST PROFITABLE REVENUE POCKETS FOR BLOOD SCREENING MARKET IN THE FORECAST PERIOD FROM 2018 TO 2025 49

FIGURE 16 ASIA-PACIFIC BLOOD SCREENING MARKET: BY PRODUCTS & SERVICES, 2017 51

FIGURE 17 ASIA-PACIFIC BLOOD SCREENING MARKET: BY TECHNOLOGY, 2017 62

FIGURE 18 ASIA-PACIFIC BLOOD SCREENING MARKET: BY DISEASE TYPE, 2017 74

FIGURE 19 ASIA-PACIFIC BLOOD SCREENING MARKET: BY END USER, 2017 85

FIGURE 20 ASIA-PACIFIC BLOOD SCREENING MARKET SNAPSHOT (2017) 92

?

FIGURE 21 ASIA-PACIFIC BLOOD SCREENING MARKET: BY COUNTRY (2017) 93

FIGURE 22 ASIA-PACIFIC BLOOD SCREENING MARKET: BY COUNTRY (2018 & 2025) 93

FIGURE 23 ASIA-PACIFIC BLOOD SCREENING MARKET: BY COUNTRY (2017 & 2025) 94

FIGURE 24 ASIA-PACIFIC BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES (2018 TO 2025) 94

FIGURE 25 ASIA-PACIFIC BLOOD SCREENING MARKET MARKET: COMPANY SHARE 2017 (%) 174

LIST OF TABLES

TABLE 1 LIST OF PRICES FOR FEW DEVICES 42

TABLE 2 ASIA-PACIFIC BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025, (USD MILLION) 53

TABLE 3 ASIA-PACIFIC REAGENTS & KITS IN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 54

TABLE 4 ASIA-PACIFIC REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 55

TABLE 5 ASIA-PACIFIC ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 56

TABLE 6 ASIA-PACIFIC NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 57

TABLE 7 ASIA-PACIFIC INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 59

TABLE 8 ASIA-PACIFIC INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) 59

TABLE 9 ASIA-PACIFIC INSTRUMENTS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 60

TABLE 10 ASIA-PACIFIC SOFTWARE & SERVICES IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 61

TABLE 11 ASIA-PACIFIC BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 64

TABLE 12 ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) 65

TABLE 13 ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) 66

TABLE 14 ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY REGION , 2016-2025 (USD MILLION) 66

TABLE 15 ASIA-PACIFIC RAPID TESTS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 68

TABLE 16 ASIA-PACIFIC NEXT-GENERATION SEQUENCING (NGS) IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 69

TABLE 17 ASIA-PACIFIC NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 70

TABLE 18 ASIA-PACIFIC NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 70

TABLE 19 ASIA-PACIFIC WESTERN BLOT ASSAY IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 72

TABLE 20 ASIA-PACIFIC OTHERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 73

TABLE 21 ASIA-PACIFIC BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) 76

TABLE 22 ASIA-PACIFIC ONCOLOGY IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 77

TABLE 23 ASIA-PACIFIC DIABETES MELLITUS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 78

TABLE 24 ASIA-PACIFIC COLD & FLU IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 79

TABLE 25 ASIA-PACIFIC CHOLESTEROL IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 80

TABLE 26 ASIA-PACIFIC INFECTIOUS DISEASES IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 81

TABLE 27 ASIA-PACIFIC RESPIRATORY DISEASESIN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 82

TABLE 28 ASIA-PACIFIC HIV/AIDS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 83

TABLE 29 ASIA-PACIFIC OTHERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 84

TABLE 30 ASIA-PACIFIC BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) 87

TABLE 31 ASIA-PACIFIC DIAGNOSTIC CENTERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 88

TABLE 32 ASIA-PACIFIC BLOOD BANK IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 89

TABLE 33 ASIA-PACIFIC HOSPITALS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 90

TABLE 34 ASIA-PACIFIC CLINICS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 91

TABLE 35 ASIA-PACIFIC AMBULATORY SURGICAL CENTERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 92

TABLE 36 ASIA-PACIFIC HOME HEALTHCARE MARKET, BY COUTRY, 2016-2025 (USD MILLION) 96

TABLE 37 ASIA-PACIFIC BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 97

TABLE 38 ASIA-PACIFIC BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 97

TABLE 39 ASIA-PACIFIC ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 98

TABLE 40 ASIA-PACIFIC NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 98

TABLE 41 ASIA-PACIFIC INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 99

TABLE 42 ASIA-PACIFIC INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) 99

TABLE 43 ASIA-PACIFIC BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 100

TABLE 44 ASIA-PACIFIC NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 100

TABLE 45 ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) 101

TABLE 46 ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) 101

TABLE 47 ASIA-PACIFIC BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) 102

TABLE 48 ASIA-PACIFIC BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) 103

TABLE 49 CHINA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 104

TABLE 50 CHINA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 104

TABLE 51 CHINA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 105

TABLE 52 CHINA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 106

TABLE 53 CHINA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 106

TABLE 54 CHINA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) 107

TABLE 55 CHINA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 107

TABLE 56 CHINA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 108

TABLE 57 CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) 108

TABLE 58 CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) 109

TABLE 59 CHINA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) 109

TABLE 60 CHINA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) 110

TABLE 61 JAPAN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 111

TABLE 62 JAPAN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 111

TABLE 63 JAPAN ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 112

TABLE 64 JAPAN NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 113

TABLE 65 JAPAN INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 113

TABLE 66 JAPAN INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) 114

TABLE 67 JAPAN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 114

TABLE 68 JAPAN NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 115

TABLE 69 JAPAN ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) 115

TABLE 70 JAPAN ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) 116

TABLE 71 JAPAN BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) 116

TABLE 72 JAPAN BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) 117

TABLE 73 SOUTH KOREA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 118

TABLE 74 SOUTH KOREA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 118

TABLE 75 SOUTH KOREA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 119

TABLE 76 SOUTH KOREA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 120

TABLE 77 SOUTH KOREA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 120

TABLE 78 SOUTH KOREA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) 121

TABLE 79 SOUTH KOREA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 121

TABLE 80 SOUTH KOREA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 122

TABLE 81 SOUTH KOREA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) 122

TABLE 82 SOUTH KOREA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) 123

TABLE 83 SOUTH KOREA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) 123

TABLE 84 SOUTH KOREA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) 124

TABLE 85 INDIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 125

TABLE 86 INDIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 125

TABLE 87 INDIA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 126

TABLE 88 INDIA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 127

TABLE 89 INDIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 127

TABLE 90 INDIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) 128

TABLE 91 INDIA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 128

TABLE 92 INDIA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 129

TABLE 93 INDIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) 129

TABLE 94 INDIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) 130

TABLE 95 INDIA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) 130

TABLE 96 INDIA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) 131

TABLE 97 SINGAPORE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 132

TABLE 98 SINGAPORE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 132

TABLE 99 SINGAPORE ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 133

TABLE 100 SINGAPORE NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 134

TABLE 101 SINGAPORE INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 134

TABLE 102 SINGAPORE INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) 135

TABLE 103 SINGAPORE BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 135

TABLE 104 SINGAPORE NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 136

TABLE 105 SINGAPORE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) 136

TABLE 106 SINGAPORE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) 137

TABLE 107 SINGAPORE BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) 137

TABLE 108 SINGAPORE BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) 138

TABLE 109 AUSTRALIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 139

TABLE 110 AUSTRALIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 139

TABLE 111 AUSTRALIA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 140

TABLE 112 AUSTRALIA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 141

TABLE 113 AUSTRALIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 141

TABLE 114 AUSTRALIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) 142

TABLE 115 AUSTRALIA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 142

TABLE 116 AUSTRALIA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 143

TABLE 117 AUSTRALIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) 143

TABLE 118 AUSTRALIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) 144

TABLE 119 AUSTRALIA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) 144

TABLE 120 AUSTRALIA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) 145

TABLE 121 THAILAND BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 146

TABLE 122 THAILAND BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 146

TABLE 123 THAILAND ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 147

TABLE 124 THAILAND NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 148

TABLE 125 THAILAND INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 148

TABLE 126 THAILAND INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) 149

TABLE 127 THAILAND BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 149

TABLE 128 THAILAND NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 150

TABLE 129 THAILAND ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) 150

TABLE 130 THAILAND ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) 151

TABLE 131 THAILAND BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) 151

TABLE 132 THAILAND BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) 152

TABLE 133 MALAYSIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 153

TABLE 134 MALAYSIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 153

TABLE 135 MALAYSIA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 154

TABLE 136 MALAYSIA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 155

TABLE 137 MALAYSIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 155

TABLE 138 MALAYSIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) 156

TABLE 139 MALAYSIA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 156

TABLE 140 MALAYSIA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 157

TABLE 141 MALAYSIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) 157

TABLE 142 MALAYSIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) 158

TABLE 143 MALAYSIA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) 158

TABLE 144 MALAYSIA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) 159

TABLE 145 INDONESIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 160

TABLE 146 INDONESIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 160

TABLE 147 INDONESIA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 161

TABLE 148 INDONESIA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 161

TABLE 149 INDONESIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 162

TABLE 150 INDONESIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) 162

TABLE 151 INDONESIA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 163

TABLE 152 INDONESIA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 163

TABLE 153 INDONESIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) 164

TABLE 154 INDONESIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) 164

TABLE 155 INDONESIA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) 165

TABLE 156 INDONESIA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) 166

TABLE 157 PHILIPPINES BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 167

TABLE 158 PHILIPPINES BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 167

TABLE 159 PHILIPPINES ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 168

TABLE 160 PHILIPPINES NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 169

TABLE 161 PHILIPPINES INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 169

TABLE 162 PHILIPPINES INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) 170

TABLE 163 PHILIPPINES BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 170

TABLE 164 PHILIPPINES NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 171

TABLE 165 PHILIPPINES ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) 171

TABLE 166 PHILIPPINES ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) 172

TABLE 167 PHILIPPINES BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) 172

TABLE 168 PHILIPPINES BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) 173

TABLE 169 REST OF ASIA-PACIFIC BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 174

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Enzo Biochem Inc.

Meridian Bioscience, Inc.

Bio-Rad Laboratories, Inc.

Thermo Fisher Scientific Inc.

BD

bioMerieux SA

Beckman Coulter, Inc.

Abbott

F. Hoffmann-La Roche Ltd

Cepheid

Grifols

Seimens AG

Ortho Clinical Diagnostics

Immucor, Inc.

Hologic Inc.

select a license
Single User License
USD 2500 INR 179750
Corporate User License
USD 3200 INR 230080

NEWSLETTER BY CATEGORY




Testimonials

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com